In vivo–activated CD103(+)CD4(+) regulatory T cells ameliorate ongoing chronic graft-versus-host disease

CD103 (αEβ7) has been shown to be an excellent marker for identifying in vivo–activated FoxP3(+)CD4(+) regulatory T (Treg) cells. It is unknown whether reinfusion of in vivo–activated donor-type CD103(+) Treg cells from recipient can ameliorate ongoing chronic graft-versus-host disease (GVHD). Here,...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Zhao, Dongchang, Zhang, Chunyan, Yi, Tangsheng, Lin, Chia-Lei, Todorov, Ivan, Kandeel, Fouad, Forman, Stephen, Zeng, Defu
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2008
Témata:
Transplantation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2518910/
https://ncbi.nlm.nih.gov/pubmed/18550852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-02-140277
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky